Britain to offer under-30s an alternative to AstraZenca vaccine over blood clot concerns

In a separate decision, the European Medicines Agency said it would list the blood clots as a “very rare” side effect of the vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *